Bioanalysis Zone

24/07/2025

New interview available🗞️🖥️

Nathan Teuscher, Founder and President of Aplos Analytics, Inc. relays his vision for building Aplos — to modernize and streamline pharmacokinetic analysis.

Read the full interview here >>>

In this interview, Nathan Teuscher, Founder and President of Aplos Analytics, relays his vision for building Aplos — to modernize and streamline PK analysis.

23/07/2025

Researchers from The University of Chicago have demonstrated how RNA modification analysis enables highly accurate cancer detection, surpassing traditional DNA methods.

Read the full story here >>>

Researchers have used RNA modifications to detect early-stage cancer, with higher accuracy than commercial tests.

23/07/2025

Gain insight into the best practices for oligonucleotide sample preparation, cutting-edge methods for analyzing oligonucleotides and more!

Register for our webinar, in partnership with SCIEX, today >>> https://hubs.ly/Q03wcWbF0

22/07/2025

2025 Merger & Acquisitions - the first half of the year summarized🤝

The first half of 2025 has brought a wave of mergers and acquisitions that are reshaping the pharma and biotech landscape. From cancer and neuroscience breakthroughs to bioprocessing tools and diagnostics, these deals reflect a clear trend: big pharma and investors are not waiting for organic growth – they’re buying their way into the future.

We break down the most impactful M&A deals and activities so far this year, and what they mean for the industry >>>

We break down the most impactful M&A deals within pharma and biotech so far this year, and what they mean for the industry.

22/07/2025

[INFOGRAPHIC] Addressing quality standards for plasmid DNA! This infographic explores how commercial standards and analytical guidelines are shaping the future of plasmid-based therapies. From quality control challenges to practical solutions, discover the benchmarks driving consistency in CGT manufacturing >>> https://hubs.ly/Q03vG03_0
U.S. Pharmacopeia

22/07/2025

Explore IQVIA Laboratories’ company profile!
Want to stay at the forefront of bioanalytical innovation? Access new features, expert updates and service highlights in IQVIA Laboratories’ company profile.
View profile >>>

IQVIA Laboratories leads with science. For 30+ years, our highly trained bioanalytical scientists have partnered with biotech and pharma companies, providing well-planned strategies to support small and large molecule bioanalysis using LC–MS/MS, HRMS and immunoassay platforms.

17/07/2025

Peptide therapeutics offer immense potential but present complex development challenges, particularly in oral formats. Our webinar with WuXi AppTec explored how integrated DMPK, bioanalytical and toxicology strategies effectively overcome absorption, stability and safety barriers.

Watch on demand >>>

This expert-led presentation explores how integrated DMPK, bioanalytical and toxicology strategies effectively overcome absorption, stability and safety barriers.

16/07/2025

What's holding back standardization in plasmid DNA production? With limited guidance on control strategies and specifications, the gene therapy field faces crucial challenges in quality and safety. Discover how industry experts are addressing these gaps in this eBook, sponsored by U.S. Pharmacopeia >>>

Download peer-reviewed content and expert insights in our latest eBook. To conclude our Spotlight on gene therapy analytical testing, this eBook will revisit some of our highlights from the feature and explore the necessary quality standards, strategies and resources available to improve the standar...

16/07/2025

Explore cutting-edge methods for analyzing oligonucleotides in biological matrices in our 60-minute webinar in partnership with SCIEX.

Save your seat for Thursday 31 July! >>> https://hubs.ly/Q03wd1qV0

15/07/2025

While we were at WRIB 2025, we met with the team at Worldwide Clinical Trials to learn all about their large molecular laboratory and its automation capabilities.

Watch the interview here >>> https://hubs.ly/Q03wtKP40

15/07/2025

Watch our expert team from Alturas Analytics, QPS, LLC and WuXi AppTec discuss key challenges in bioanalytical work such as complex matrices, stability issues and the bridging of preclinical and clinical bioanalysis.

Catch up on the Panel discussion here >>>

This session covers the current landscape of bioanalytical method development and validation for small molecules.

11/07/2025

The U.S FDA has approved Thermo Fisher Scientific's next-generation sequencing assay as a companion diagnostic for ZEGFROVY and for tumor profiling.

Read the fully story here >>

The U.S Food and Drug Administration has approved Thermo Fisher Scientific's NGS assay, the Oncomine Dx Express Test.